Media Coverage

The laws about marijuana in Wisconsin aren't changing. But recent legalization of recreational marijuana in neighboring states and shifting societal norms are causing employers to rethink how to treat cannabis use. [CR-LF][CR-LF]Calls to MRA's human resources hotline about workplace drug testing increased in recent months. Employers are asking just how exactly the changing tides will affect them. [CR-LF][CR-LF]The laboratories that carry out employer-based drug testing, such as Quest Diagnostics, do not see evidence that people are abandoning the practice, said Quest Diagnostics Director of Science and Technology Barry Sample.

Quest Diagnostics Incorporated announced today the pricing of a public offering of $800 million aggregate principal amount of its 2.950% senior notes due 2030 under the Quest Diagnostics' shelf registration statement.

North Carolina’s governor has announced that a clinical trial lab services provider will add 749 jobs at a new facility over the next few years.[CR-LF][CR-LF]Gov. Roy Cooper issued a statement Wednesday that Q Squared Solutions LLC will invest $73 million in the Durham-based facility that’s expected to grow over seven years.The company is described as a joint venture between IQVIA and Quest Diagnostics that offers laboratory services and biospecimen management among other services.

For blockchain to be successful in healthcare, it needs to scale. This is why collaborations have been created between major healthcare organizations to grow the technology.[CR-LF][CR-LF]In April 2018, five healthcare giants — Humana, MultiPlan, Quest Diagnostics, UnitedHealthcare Group and Optum, launched the Synaptic Health Alliance, a pilot program using blockchain to ensure health plan provider directors include up-to-date physician information.[CR-LF][CR-LF]Since then, St. Louis-based Ascension and Aetna have joined the project.

As the United States tries to wean off prescription opioids, physicians worry about the impact on chronic pain patients: Doctors are concerned that many chronic pain patients will turn to illicit drugs if they do not have access to prescription opioids, according to a new report from Quest Diagnostics. For the report, researchers polled 500 primary care physicians (PCPs) and analyzed 4.4 million lab test results.